BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5923170)

  • 21. Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Dec; 27(12):2267-71. PubMed ID: 4866760
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison by several techniques of the antibody prepared in various species against the Rauscher murine leukemia virus.
    Fink MA; Cowles CA; Chirigos MA; Messore J
    Natl Cancer Inst Monogr; 1966 Sep; 22():439-47. PubMed ID: 4958836
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of mouse antiserum against isologous aggregated immunoglobulins on the transplantation and antitumor immunity].
    Kaulen DR; Snegireva AE; Khorobrykh VV; Shevliagin VIa; Prigoda OS
    Biull Eksp Biol Med; 1979 May; 87(5):438-41. PubMed ID: 378289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of skin in gross leukemia. II. Kinetic, preleukemic, and irradiation studies.
    Mariani T; Maruyama Y; Good RA
    J Natl Cancer Inst; 1971 Aug; 47(2):361-6. PubMed ID: 4934424
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possible mechanism of the resistance of C57Bl/6 mice to a mixed infection with Mycoplasma arthritidis and Rauscher leukemia virus].
    Sanin AV; Rakovskaia IV; Khorobrykh VV
    Mikrobiol Zh (1978); 1981; 43(2):199-202. PubMed ID: 7231223
    [No Abstract]   [Full Text] [Related]  

  • 26. Purification of a glycoprotein bearing a tumor transplantation antigen specific for Friend, Moloney, and Rauscher MuLV-induced tumors.
    Rogers MJ; Galetto G; Hearing VJ; Siwarski DF; Law LW
    J Immunol; 1984 Jun; 132(6):3211-7. PubMed ID: 6202777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of 7S- and 19S-antibodies in the mechanism of stimulation and inhibition of Rauscher virus leukemia in mice].
    Ter-Grigorov VS; Shevelev BI; Moskovkina OIa; Bergol'ts VM
    Biull Eksp Biol Med; 1971 Jan; 71(1):61-4. PubMed ID: 5552664
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukemic transformation of donor spleen cells following their transplantation into superlethally irradiated mice with pre-existing viral leukemia.
    Kuhnert PM; OKunewick JP; Erhard
    Exp Hematol; 1974; 2(6):328-35. PubMed ID: 4156671
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioprotective effect of Rauscher Leukemia virus in the SJL-J mouse. 3. Relationship of hematologic factors and splenomegaly to the development of radioresistance.
    Markoe AM; Okunewick JP
    Radiat Res; 1973 Mar; 53(3):428-34. PubMed ID: 4696649
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunogenetic control over the spontaneous regression of Rauscher leukemia in mice].
    Klepikov NN
    Dokl Akad Nauk SSSR; 1980; 255(1):250-2. PubMed ID: 7460751
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of macrophages in defense against the development of Rauscher virus leukemia.
    Knyszynski A; Danon D
    J Reticuloendothel Soc; 1977 Oct; 22(4):341-8. PubMed ID: 926089
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective effect of specific immunization in Rauscher leukemia.
    Barski G; Youn JK
    Natl Cancer Inst Monogr; 1966 Sep; 22():659-69. PubMed ID: 5923334
    [No Abstract]   [Full Text] [Related]  

  • 33. [Decline of the malignancy of a cell strain in mice follwoing chronic infection in vitro by the Rauscher leukemia virus].
    Barbieri D; Barski G
    Rev Fr Etud Clin Biol; 1968; 13(7):703-6. PubMed ID: 5726635
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells.
    Martyré MC; Halle-Pannenko O; Jollès P
    Eur J Cancer (1965); 1973 Oct; 9(10):757-61. PubMed ID: 4803219
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
    Novichenko NL; Struk VI
    Eksp Onkol; 1984; 6(3):29-32. PubMed ID: 6499739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioprotective effect of Rauscher leukemia virus in the SJL-J mouse.
    Okunewick JP; Fulton D; Markoe AM
    Radiat Res; 1972 Mar; 49(3):521-9. PubMed ID: 5012865
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitation and ultrastructure of immunodepression in murine virus-induced leukemia.
    Siegel BV; Neher GH; Morton JI
    Lab Invest; 1969 Apr; 20(4):347-52. PubMed ID: 5776328
    [No Abstract]   [Full Text] [Related]  

  • 39. [Group and type specific antigens of Rauscher viral leukemia].
    Engel'gardt NV; Abelev GI; Ievleva ES
    Vopr Onkol; 1969; 15(10):76-84. PubMed ID: 4984573
    [No Abstract]   [Full Text] [Related]  

  • 40. The erythrocyte as virus carrier in Friend and Rauscher virus leukemias.
    Reilly CA; Schloss GT
    Cancer Res; 1971 Jun; 31(6):841-6. PubMed ID: 5088488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.